Literature DB >> 33136015

Influence of Changes in Bone-Conduction Thresholds on Speech Audiometry in Patients Who Underwent Surgery for Otosclerosis.

Agnieszka Wiatr1, Maciej Wiatr1.   

Abstract

OBJECTIVES: Otosclerosis is an underlying disease of the bony labyrinth that results in hearing loss. In some cases, the involvement of the bony part of the cochlea results in mixed hearing loss. The aim of this analysis was to seek a correlation between the results of speech audiometry tests and the changes in bone-conduction thresholds observed after surgical treatment.
MATERIALS AND METHODS: The analysis included 140 patients who were hospitalized and surgically treated for otosclerosis. The patients who were treated with stapedotomy were divided into subgroups based on the value of the bone-conduction threshold before the surgery. An audiological assessment was performed, with pure-tone threshold audiometry and speech audiometry tests taken into account.
RESULTS: The effectiveness of the surgery was judged by the change in the speech audiometry test results after 12 months of observation. After the surgery, it was found that a significant improvement, characterized as achieving 100% understanding of speech, occurred in 61.90% of the patients.
CONCLUSION: There is a correlation between the improvement in speech audiometry tests and bone-conduction curve after stapedotomy. The changes achieved in the bone-conduction curve at the frequency range up to 3,000 Hz (hertz) had a significant impact on the improvements in speech audiometry test results. Higher frequencies provide more data for improving the hearing process. A mean bone-conduction threshold between 21 and 40 dB (decibels) in the pure-tone audiometry examination performed before surgery is a favorable prognostic factor in the improvement of the bone-conduction threshold after surgery.

Entities:  

Year:  2020        PMID: 33136015      PMCID: PMC7901459          DOI: 10.5152/iao.2020.8139

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  13 in total

1.  [Speech understanding in patients after stapedectomy (early results)].

Authors:  W Konopka; P Zalewski; J Olszewski
Journal:  Otolaryngol Pol       Date:  2000

2.  [Otosclerosis].

Authors:  K FLEISCHER
Journal:  Z Arztl Fortbild (Jena)       Date:  1959-11-01

3.  [30 years of stapes surgery].

Authors:  Tatiana Gierek; Lucyna Klimczak-Gołab; Danuta Zbrowska-Bielska; Krystyna Majzel; Wojciech Smółka; Grazyna Gawlicka
Journal:  Otolaryngol Pol       Date:  2004

4.  Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. AmericanAcademy of Otolaryngology-Head and Neck Surgery Ffoundation, Inc.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

5.  Improvement of hearing results by bone cement fixation in endoscopic stapedotomy.

Authors:  F N Ardiç; K Aykal; F Tümkaya; C O Kara; F Barlay
Journal:  J Laryngol Otol       Date:  2018-06-11       Impact factor: 1.469

6.  The diagnosis and treatment of active cochlear otosclerosis.

Authors:  G E Shambaugh
Journal:  J Laryngol Otol       Date:  1971-04       Impact factor: 1.469

7.  Comparison of Audiometric and Functional Outcomes Between the Standard and Modified 360 Nitinol Shape Memory Stapes Prostheses.

Authors:  Jeremy Lavy; Charlie Huins; Sherif Khalil; Andrew Hall; Owain Hughes
Journal:  Otol Neurotol       Date:  2015-09       Impact factor: 2.311

Review 8.  [Otosclerosis. 1st part: pathogenesis].

Authors:  Balázs Liktor; Andor Hirschberg; Tamás Karosi
Journal:  Orv Hetil       Date:  2018-07       Impact factor: 0.540

9.  Perception of nonlinear distortion by hearing-impaired people.

Authors:  Chin-Tuan Tan; Brian C J Moore
Journal:  Int J Audiol       Date:  2008-05       Impact factor: 2.117

10.  Factors affecting fenestration of the footplate in stapes surgery: effectiveness of Fisch's reversal steps stapedotomy.

Authors:  Hiromi Ueda; Mayuko Kishimoto; Yasue Uchida; Michihiko Sone
Journal:  Otol Neurotol       Date:  2013-12       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.